Petefészekrák: vizsgálatok itt: Olaszország
100 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 12.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleStudy of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Where
- Ancona, Aviano, Meldola, Milan, Naples, Orbassano, Ravenna, Verona
- Életkor
- 18 év and over
- People
- 534 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT06128551 - 1. fázisTaking peopleEvaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Where
- Candiolo, Rozzano
- Életkor
- 18 év and over
- People
- 540 worldwide
- Run by
- SystImmune Inc.
See details and how to joinNCT05983432 - No phaseNot yet taking people in OlaszországHomologous Recombination Repair Deficiency (HRD) Testing in Newly Diagnosed Advanced-stage Epithelial Ovarian Cancer in Italy
- Where
- Rome
- Életkor
- 18 év and over
- People
- 1125
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT07825181 - 2. fázisTaking people[68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
- Where
- Bergamo, Milan, Monza, Rome
- Életkor
- 18 év to 79 év
- People
- 71 worldwide
- Run by
- Blue Earth Diagnostics
See details and how to joinNCT07702292 · EU 2025-521983-36-00 - 3. fázisTaking peopleMinimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
- Where
- Bologna, Rome
- Életkor
- 18 év and over
- People
- 580 worldwide
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT04575935 - No phaseTaking peopleORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Where
- Meldola, Reggio Emilia, Roma
- Életkor
- 18 év and over
- People
- 2285 worldwide
- Run by
- Guardant Health, Inc.
See details and how to joinNCT05059444 - No phaseTaking peopleSetting Up ctDNA Analysis on Archived Plasma Samples
- Where
- Roma
- Életkor
- 18 év and over
- People
- 50
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT07546578 - 2/3. fázisTaking peopleRecurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib
- Where
- Bologna, Catania, Meldola, Milan, Naples, Roma, Torino
- Életkor
- 18 év and over
- People
- 138 worldwide
- Run by
- ARCAGY/ GINECO GROUP
See details and how to joinNCT03651206 - No phaseNot yet taking people in OlaszországHERCULES: Ultrasound-Based Liver Involvement Classification in Ovarian Cancer
- Where
- Roma
- Életkor
- 18 év and over
- People
- 20
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT07808320 - No phaseNot yet taking people in OlaszországFetal Ovarian Cysts and IOTA Terminology for Perinatal Management
- Where
- Roma
- Életkor
- 18 év and over
- People
- 100
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT07587580 - No phaseNot yet taking people in OlaszországMachine Learning Algorithms Incorporating Radiomic Ultrasound Features
- Where
- Roma
- Életkor
- 18 év and over
- People
- 12 000
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT07793201 - 1/2. fázisTaking peopleA Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- Where
- Bologna, Milan, Rome, Rozzano
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04104776 · EU 2023-508002-20-00 - 1/2. fázisTaking peopleA Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Where
- Candiolo, Milan, Naples, Roma, Rozzano, Siena
- Életkor
- 18 év and over
- People
- 1109 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT04895709 - 3. fázisTaking peopleUtility of Adjusting Chemotherapy Dose & Dosing Schedule With the SALVage Weekly Dose-dense Regimen in Patients With Poor Prognostic OVARian Cancers Based on the Tumor Unfavorable Primary Chemosensitivity and Incomplete Debulking Surgery
- Where
- Alessandria, Bologna, Florence, Lecco, Milan, Venice
- Életkor
- 18 év and over
- People
- 250 worldwide
- Run by
- ARCAGY/ GINECO GROUP
See details and how to joinNCT06476184 - 2. fázisTaking peopleA Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Where
- Meldola, Milan, Naples
- Életkor
- 8 év and over
- People
- 254 worldwide
- Run by
- Fore Biotherapeutics
See details and how to joinNCT05503797 · EU 2024-513578-23-00 - No phaseTaking peopleA Study to Evaluate Folate Receptor Alpha (FRα) Expression in Adult Participants With Ovarian, Fallopian Tube, and Primary Peritoneal Cancer in Italy
- Where
- Rome
- Életkor
- 18 év and over
- People
- 200
- Run by
- AbbVie
See details and how to joinNCT07407062 - No phaseTaking peopleCentralization and Oncologic Outcomes in Ovarian Cancer
- Where
- Carpi, Mirandola, Modena, Pavullo nel Frignano, Reggio Emilia, Sassuolo, Vignola
- Életkor
- 18 év to 99 év
- People
- 200
- Run by
- Azienda USL Reggio Emilia - IRCCS
See details and how to joinNCT07075939 - No phaseTaking peopleIdentifying Genetic Targets in Gynecological Tumors
- Where
- Reggio Emilia
- Életkor
- 18 év and over
- People
- 180
- Run by
- Azienda USL Reggio Emilia - IRCCS
See details and how to joinNCT07169396 - 3. fázisTaking peopleAZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
- Where
- Brescia, Catania, Florence, Lecco, Milan, Naples, Parma, Pisa, Rome, Torino
- Életkor
- 18 év and over
- People
- 1100 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07218809 · EU 2025-520466-22-00 - 1. fázisTaking peopleA Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.
- Where
- Milan
- Életkor
- 18 év and over
- People
- 240 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06476808 · EU 2025-523067-38-01 - 2. fázisTaking peopleRelacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
- Where
- Catania, Milan, Pavia, Rome, Torino, Treviso
- Életkor
- 18 év and over
- People
- 270 worldwide
- Run by
- Corcept Therapeutics
See details and how to joinNCT06906341 - 1/2. fázisTaking peopleFirst-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Where
- Alexandria, Brescia, Milan, Monza, Pisa, Ravenna, Rome, Verona
- Életkor
- 18 év and over
- People
- 880 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT05768139 · EU 2023-504807-94-00 - 1/2. fázisTaking peopleA study of niraparib in combination with abemaciclib for late line treatment of ovarian cancer: a single center, open label, single arm, phase Ib/II trial (NICHOL TRIAL)
- Where
- Milan
- Életkor
- 18 év and over
- People
- 73
- Run by
- Fondazione IRCCS Istituto Nazionale Dei Tumori
See details and how to join2022-501910-79-01 · EU 2022-501910-79-01 - 2. fázisTaking peopleA Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
- Where
- Cremona
- Életkor
- 18 év and over
- People
- 37 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT04641247 · EU 2023-506618-29-00 - No phaseNot yet taking people in OlaszországEvaluation of Interactions and Group Processes in Multidisciplinary Tumor Boards in Gynecologic Oncology
- Where
- Roma
- Életkor
- 18 év and over
- People
- 400
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT07645716